Form D · Biotechnology
Valeritas Holdings Inc.
Bridgewater, NJ · CIK 0001619250
Offering snapshot reported May 18, 2016 · SEC filing
- Reported sold
- $33M Offering amount: $33M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2016 | Initial | $33,000,000 | No comparison | 26 | SEC filing |
| May 18, 2016 | Initial | $25,195,000 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263380
Represents aggregate value of the shares of the Issuer's common stock issued to shareholders of Valeritas, Inc. in connection with the merger.
Source: Form D, filed May 18, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rodney Altman | Director |
| Mark Conley | Executive |
| Peter Devlin | Director |
| Luke Duster | Director |
| Cameron Hui | Director |
| Nathan Hukill | Director |
| Geoffrey Jenkins | Executive |
| Matthew Nguyen | Executive |
| John Timberlake | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
750 Route 202 South Suite 600
Bridgewater, NJ, 08807
Bridgewater, NJ, 08807